Clay B. Siegall
2020
In 2020, Clay B. Siegall earned a total compensation of $16.5M as President and CEO at Seattle Genetics, a 14% increase compared to previous year.
Compensation breakdown
| Bonus | $9,295,156 |
|---|---|
| Non-Equity Incentive Plan | $1,575,900 |
| Option Awards | $4,561,723 |
| Salary | $1,043,651 |
| Other | $17,127 |
| Total | $16,493,557 |
Siegall received $9.3M in bonus, accounting for 56% of the total pay in 2020.
Siegall also received $1.6M in non-equity incentive plan, $4.6M in option awards, $1M in salary and $17.1K in other compensation.
Rankings
In 2020, Clay B. Siegall's compensation ranked 332nd out of 13,090 executives tracked by ExecPay. In other words, Siegall earned more than 97.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 332 out of 13,090 | 98th |
Division Manufacturing | 113 out of 5,621 | 98th |
Major group Chemicals And Allied Products | 38 out of 2,254 | 98th |
Industry group Drugs | 34 out of 1,954 | 98th |
Industry Biological Products, Except Diagnostic Substances | 12 out of 411 | 97th |
Source: SEC filing on March 30, 2022.
Siegall's colleagues
We found four more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2020.